肥胖,糖尿病和炎症:病理生理学和临床影响
Marc Y Donath1, Daniel J Drucker2
1Integrated Centre of Excellence in Metabolic Health and Endocrine Division, Department of Medicine and Centre de Recherche, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.
Immunity
|October 4, 2025
概括
肥胖会导致慢性炎症,导致代谢疾病. 葡萄糖类-1 (GLP-1) 受体激动剂表现出抗炎作用,为这些疾病提供新的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖和相关疾病 (2型糖尿病,心血管,肝脏,脏疾病) 是慢性炎症性疾病.
- 营养过多会激活免疫路径,如模式识别受体和NLRP3炎症体,产生IL-1β和细胞因子.
- 慢性炎症有助于胰岛素抵抗,β细胞功能障碍和末端器官损伤.
研究的目的:
- 审查肥胖相关疾病中炎症的机制.
- 讨论葡萄糖类-1 (GLP-1) 受体激活剂的抗炎作用.
- 探索慢性炎症疾病的治疗潜力.
主要方法:
- 对有关代谢疾病中的炎症现有文献的综述.
- 分析因营养过多而引发的免疫激活通路.
- 检查GLP-1受体激动剂的机制和作用.
主要成果:
- 营养过多会触发免疫激活,最初是适应性的,但慢性损害.
- GLP-1受体激动剂显示出显著的抗炎作用.
- 这些影响可以独立于血糖控制或体重减轻,通过直接GLP-1R信号传递和中枢神经系统通路进行介导.
结论:
- 了解肥胖的炎症机制对于疾病管理至关重要.
- GLP-1受体激动剂由于其抗炎性质,提供了有前途的治疗策略.
- 准GLP-1R信号可能会解锁慢性炎症疾病的新疗法.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Psychoneuroimmunology: Diabetes and Cancer
449
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
449
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
246
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
246


